Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Postoperative Urinary Retention Prevention in Hernia Repair
NCT04434378Phase 4Terminated
- Sponsor
- The Jewish Hospital - Mercy Health
- Start
- Nov 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamsulosin in postoperative urinary retention (POUR), sponsored by The Jewish Hospital - Mercy Health. Started Nov 2017; status: terminated.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT04434378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434378.